The detection of antibody against active site of botulinum toxin A and complexing protein before and after using botulinum toxi
Phase 1
Completed
- Conditions
- Healthy human volunteersBotulinum Toxins, Antibody
- Registration Number
- TCTR20220214001
- Lead Sponsor
- Dermatologic Surgery, Dermatology department, Siriraj hospital, Thailand
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
1. Healthy male or female volunteers age 18-60 years
2. No history of botulinum toxin treatment failure
3. No history of immunodeficiency disease or taking any immunosuppressive drug
Exclusion Criteria
1. pregnant or lactating woman
2. Was treated with botulinum toxin during 6 months prior
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method